Previous close | 0.6600 |
Open | N/A |
Bid | 0.0000 |
Ask | 5.0000 |
Strike | 17.50 |
Expiry date | 2024-06-21 |
Day's range | 0.6600 - 0.6600 |
Contract range | N/A |
Volume | |
Open interest | 1 |
On June 3, 2024, Julie Hambleton, Director at SpringWorks Therapeutics Inc (NASDAQ:SWTX), sold 4,648 shares of the company.
Badreddin Edris, the Chief Operating Officer of SpringWorks Therapeutics Inc (NASDAQ:SWTX), sold 20,000 shares of the company on June 3, 2024, according to a recent SEC filing.
On June 3, 2024, Saqib Islam, the Chief Executive Officer of SpringWorks Therapeutics Inc (NASDAQ:SWTX), executed a sale of 49,000 shares of the company.